GLOBE

Home
Archive
About
mRNA technology was launched originally not for COVID-19 but for personalized vaccines for chronic diseases like cancer. Can we do a better job this second time around?
Ed Kelley, Ph.D.
After pages of goals and recommendations on responding to COVID-19 and preparing for the next pandemic, one thing is still lacking: leadership
Ed Kelley, Ph.D.
By Don Berwick and Ed Kelley
The chasm between the West and rest on healthcare quality and access seems insoluble. But we can narrow the gap.
Dr Paul Rutter

Most popular

Ed Kelley, Ph.D.
Jane Chen
Ed Kelley, Ph.D.
Ed Kelley, Ph.D.
Dr Paul Rutter
Ed Kelley, Ph.D.
See all popular
New
The Lessons We Can, and Cannot, Take
Ed Kelley, Ph.D.
Seeking to improve global health access? Learn to leverage limits and constraints as springboards for innovation
Jane Chen
They are the children that modern medicine forgot, or utterly failed to reach.
Dr Paul Rutter
Traditional funding streams continue to favor northern institutions. Is it time to change?
Ed Kelley, Ph.D.
Very few people had heard of monkeypox a month ago. Now – despite tough competition from other major global events – it is high in the headlines.
Dr Paul Rutter
Thinking about known-unknowns and unknown-unknowns.
Dr Paul Rutter
Why Unsafe Injections Remain a Global Challenge
Ed Kelley, Ph.D.
We have plenty of COVID vaccines and doses. The real challenge now is delivering them the last mile.
Ed Kelley, Ph.D.
See all

Most popular

Ed Kelley, Ph.D.
Jane Chen
Ed Kelley, Ph.D.
Ed Kelley, Ph.D.
Dr Paul Rutter
Ed Kelley, Ph.D.
See all popular

GLOBE

Insights on global health issues and stories, from leaders at the ApiJect Global Health and Innovation teams. Learn more at apiject.com.

GLOBE

AboutArchiveSitemap
© 2023 ApiJect Global Initiative
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing